Key | % Net Assets |
---|---|
Pfizer | 4.4% |
US Treasury N/B 0.875% 2016-11-30 | 3.6% |
US Treasury N/B 0.375% 2015-03-15 | 3.6% |
Aviva | 3.1% |
Other | 85.3% |
Name | % Net Assets |
---|---|
Pfizer | 4.4% |
US Treasury N/B 0.875% 2016-11-30 | 3.6% |
US Treasury N/B 0.375% 2015-03-15 | 3.6% |
Aviva | 3.1% |
BT Group | 3.1% |
Sumitomo Mitsui Financial Group | 3.1% |
Sara Lee | 2.9% |
Pearson | 2.5% |
Royal Bank of Scotland | 2.3% |
Nippon Telegraph and Telephone | 2.3% |
No asset data available.
Date | 21-Nov-2024 |
---|---|
NAV | 4,442.17p |
Currency | GBP |
Change | 35.68p |
% | 0.81% |
YTD change | 616.76p |
YTD % | 16.12% |
Fund Inception | 09/01/1984 |
---|---|
Fund Manager | Andrew Green |
TER | 1.70 (31-Dec-2010) |
Minimum Investment | |
---|---|
Initial | £6000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.35% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.09 |
You are here: research